Access cutting-edge chronic spontaneous urticaria treatment through this clinical trial at a research site in San Diego. Study-provided care at no cost to qualified participants.
Access chronic spontaneous urticaria specialists in San Diego at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic spontaneous urticaria treatment provided free
This trial will be performed as a three-part dose escalating clinical trial where Parts 1 is open label and Parts 2 and 3 are randomized, double-blinded, and placebo-controlled. The trial is intended to determine the safety and tolerability and assess the preliminary efficacy of briquilimab in adult participants with chronic spontaneous urticaria (CSU), who remain symptomatic despite treatment with H1 antihistamines and omalizumab. Additionally, pharmacokinetic (PK) properties of briquilimab, a
Sponsor: Jasper Therapeutics, Inc.
Check if you qualify for this chronic spontaneous urticaria clinical trial in San Diego, CA
If you're searching for chronic spontaneous urticaria treatment options in San Diego, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Diego research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic spontaneous urticaria specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.